Article
Refine
Year of publication
- 2024 (5)
- 2023 (14)
- 2022 (14)
- 2021 (11)
- 2020 (10)
- 2019 (7)
- 2018 (12)
- 2017 (11)
- 2016 (18)
- 2015 (17)
- 2014 (23)
- 2013 (23)
- 2012 (14)
- 2011 (20)
- 2010 (10)
- 2009 (13)
- 2008 (8)
- 2007 (12)
- 2006 (12)
- 2005 (10)
- 2004 (7)
- 2003 (7)
- 2002 (13)
- 2001 (12)
- 2000 (7)
- 1999 (8)
- 1998 (17)
- 1997 (10)
- 1996 (4)
- 1995 (16)
- 1994 (15)
- 1993 (4)
- 1992 (17)
- 1991 (4)
- 1990 (7)
- 1989 (11)
- 1988 (12)
- 1987 (8)
- 1986 (5)
- 1985 (6)
- 1984 (4)
- 1983 (4)
- 1982 (3)
- 1981 (1)
- 1980 (2)
- 1979 (1)
- 1978 (2)
- 1971 (1)
Institute
- Fachbereich Chemie und Biotechnologie (472) (remove)
Language
- English (472) (remove)
Document Type
- Article (472) (remove)
Keywords
- Heparin (3)
- Bacillaceae (2)
- Biotechnological application (2)
- Butanol (2)
- Chemometrics (2)
- IR spectroscopy (2)
- NMR spectroscopy (2)
- Principal component analysis (2)
- Standardization (2)
- Subtilases (2)
The contribution of altered post-transcriptional gene silencing to the development of insulin resistance and type 2 diabetes mellitus so far remains elusive. Here, we demonstrate that expression of microRNA (miR)-143 and 145 is upregulated in the liver of genetic and dietary mouse models of obesity. Induced transgenic overexpression of miR-143, but not miR-145, impairs insulin-stimulated AKT activation and glucose homeostasis. Conversely, mice deficient for the miR-143–145 cluster are protected from the development of obesity-associated insulin resistance. Quantitative-mass-spectrometry-based analysis of hepatic protein expression in miR-143-overexpressing mice revealed miR-143-dependent downregulation of oxysterol-binding-protein-related protein (ORP) 8. Reduced ORP8 expression in cultured liver cells impairs the ability of insulin to induce AKT activation, revealing an ORP8-dependent mechanism of AKT regulation. Our experiments provide direct evidence that dysregulated post-transcriptional gene silencing contributes to the development of obesity-induced insulin resistance, and characterize the miR-143–ORP8 pathway as a potential target for the treatment of obesity-associated diabetes.
Meiotic functions of RAD18
(2011)